In May, the Association of British Insurers revealed that corporate private medical insurance (PMI) ...
Simon Mazzei, from Falcon Group, has become the lucky winner of the COVER Insight prize draw and wil...
Insurers consider product but are wary of difficulties
A simple, non-invasive skin test could be used to identify the early stages of Alzheimer's disease, ...
Cancer treatments are increasingly successful in managing the disease on a long-term basis. However, funding these drugs is becoming ever more expensive, writes Dr Gary Bolger
NHS gets approval to prescribe breast cancer drug in HER2 positive cancer after high-profile campaigning by patients
A judge recently ruled in the favour of a policyholder who had her claim rejected by Friends Provident, even though the Ombudsman had supported the provider's decision. Could this mark a shift in the way claims are dealt with in the future? While this...
IFAs have strong business confidence when it comes to the future, according to a recent study. A sur...
Despite 10 consecutive years of falling subscriptions, those in the private medical insurance market remain optimistic. Georgina Kenyon investigates their reasons for being cheerful Click here to download pdf
When the FSA announced it was to consult on over-70s regulation last month, much of the industry felt such a move was long overdue. Johanna Gornitzki reports